U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07280559) titled 'Evaluation of AI-assisted LDCT Screening in Lung Cancer' on Nov. 26.
Brief Summary: This multicenter pragmatic randomized controlled trial evaluates whether AI-assisted interpretation of low-dose CT (LDCT) improves lung cancer screening performance compared with standard reading. Eligible participants are randomized to AI-assisted or conventional interpretation. The study assesses diagnostic accuracy, efficiency, lung cancer incidence, mortality, recurrence, and smoking cessation outcomes. Results will inform the clinical utility and potential implementation of AI-assisted LDCT in routine screening practice.
Study Start Date: Dec. ...